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Adults With Attention Deficit 
Hyperactivity Disorder and 
Substance Use Disorders
Attention deficit hyperactivity disorder (ADHD) 
is one of the most common childhood mental 
disorders, and it can persist through adolescence 
and adulthood. The medications most commonly 
used to treat ADHD are stimulants, and survey 
data show that abuse of prescription stimulants 
is on the rise. This Advisory discusses the co-
occurrence of ADHD and substance use disorders 
(SUDs), the misuse of prescription stimulants, 
and treatment and prevention approaches to 
these problems.
The Definition of ADHD
According to the Diagnostic and Statistical 
Manual of Mental Disorders (5th ed.; DSM-5),1
the essential feature of ADHD is a persistent 
pattern of inattention, hyperactivity-impulsivity 
(they are grouped together), or both that interferes 
with normal functioning and development.1
The manifestations of inattention include 
wandering off task, lacking persistence, and 
being disorganized.1 Hyperactivity includes 
fidgeting, tapping, and talkativeness. Impulsivity 
is a tendency toward heedless, hasty action. (See 
Exhibit 1 for DSM-5 ADHD diagnostic criteria.)
Which ADHD symptoms are most prominent 
varies with age and circumstance. The hyper-
activity symptoms are usually the most noticeable 
during the preschool and elementary school 
years. Late in elementary and middle school, 
the inattention symptoms come to the fore.2
Among adolescents, hyperactivity may be limited 
to fidgeting and be experienced as feelings of 
jitteriness and impatience. DSM-5 notes that 
ADHD symptoms wax and wane depending 
on the circumstance. Close supervision, a new 
setting, an engrossing activity, or frequent rewards 
for appropriate behavior may make symptoms go 
away temporarily.1
Adult ADHD
For many years, experts believed that children 
and adolescents outgrew ADHD.3 However, 
research that followed children with ADHD into 
adulthood showed that the condition can persist 
into adulthood. Depending on the criteria used 
to define ADHD, anywhere from 15 percent 
(if the full criteria are used) to 65 percent (if 
cases classified as being in partial remission are 
included) of children and adolescents with ADHD 
continue to have the disorder when they are young 
adults, according to one meta-analysis.4
How Common Is ADHD?
International studies have shown that about 5 percent of children and adolescents have 
ADHD.5 The prevalence among adults is about half that, or between 2 percent and 
3.5 percent.1,6 In the United States, the number of children and adolescents diagnosed 
with ADHD has been climbing fast. In 2011, 11 percent of children and adolescents had 
been diagnosed with ADHD at some time in their lives, a 42-percent increase from 2003.7
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Exhibit 1. DSM-5 Diagnostic Criteria for ADHD
A. A persistent pattern of inattention and/or hyperactivity-
impulsivity that interferes with functioning or development, 
as characterized by (1) and/or (2):
1. Inattention: Six (or more) of the following symptoms 
have persisted for at least 6 months to a degree that 
is inconsistent with developmental level and that 
negatively impacts directly on social and academic/
occupational activities:
Note: The symptoms are not solely a manifestation 
of oppositional behavior, defiance, hostility, or failure 
to understand tasks or instructions. For older 
adolescents and adults (age 17 and older), at least 
five symptoms are required.
a. Often fails to give close attention to details or makes 
careless mistakes in schoolwork, at work, or during 
other activities (e.g., overlooks or misses details, work 
is inaccurate).
b. Often has difficulty sustaining attention in tasks or 
play activities (e.g., has difficulty remaining focused 
during lectures, conversations, or lengthy reading).
c. Often does not seem to listen when spoken to directly 
(e.g., mind seems elsewhere, even in the absence 
of any obvious distraction).
d. Often does not follow through on instructions and 
fails to finish schoolwork, chores, or duties in the 
workplace (e.g., starts tasks but quickly loses focus 
and is easily sidetracked).
e. Often has difficulty organizing tasks and activities 
(e.g., difficulty managing sequential tasks; difficulty 
keeping materials and belongings in order; messy, 
disorganized work; has poor time management; 
fails to meet deadlines).
f. Often avoids, dislikes, or is reluctant to engage 
in tasks that require sustained mental effort (e.g., 
schoolwork or homework; for older adolescents 
and adults, preparing reports, completing forms, 
reviewing lengthy papers).
g. Often loses things necessary for tasks or activities 
(e.g., school materials, pencils, books, tools, wallets, 
keys, paperwork, eyeglasses, mobile telephones).
h. Is often easily distracted by extraneous stimuli (for 
older adolescents and adults, may include unrelated 
thoughts).
i. Is often forgetful in daily activities (e.g., doing chores, 
running errands; for older adolescents and adults, 
returning calls, paying bills, keeping appointments).
2. Hyperactivity and impulsivity: Six (or more) of the 
following symptoms have persisted for at least 6 months 
to a degree that is inconsistent with developmental 
level and that negatively impacts directly on social and 
academic/occupational activities:
Note: The symptoms are not solely a manifestation 
of oppositional behavior, defiance, hostility, or a failure 
to understand tasks or instructions. For older 
adolescents and adults (age 17 and older), at least 
five symptoms are required.
a. Often fidgets with or taps hands or feet or   
squirms in seat.
b. Often leaves seat in situations when remaining 
seated is expected (e.g., leaves his or her place in 
the classroom, in the office or other workplace, or in 
other situations that require remaining in place).
c. Often runs about or climbs in situations where it is 
inappropriate. (Note: In adolescents or adults, may 
be limited to feeling restless.)
d. Often unable to play or engage in leisure activities 
quietly.
e. Is often “on the go,” acting as if “driven by a motor” 
(e.g., is unable to be or uncomfortable being still for 
extended time, as in restaurants, meetings; may be 
experienced by others as being restless or difficult 
to keep up with).
f. Often talks excessively.
g. Often blurts out an answer before a question has 
been completed (e.g., completes people’s sentences; 
cannot wait for turn in conversation).
h. Often has difficulty waiting his or her turn (e.g., while 
waiting in line).
i. Often interrupts or intrudes on others (e.g., butts into 
conversations, games, or activities; may start using 
other people’s things without asking or receiving 
permission; for adolescents and adults, may intrude 
into or take over what others are doing).
B. Several inattentive or hyperactive-impulsive symptoms 
were present prior to age 12 years.
C. Several inattentive or hyperactive-impulsive symptoms 
are present in two or more settings (e.g., at home, school, 
or work; with friends or relatives; in other activities).
D. There is clear evidence that the symptoms interfere with, 
or reduce the quality of, social, academic, or occupational 
functioning.
E. The symptoms do not occur exclusively during the course 
of schizophrenia or another psychotic disorder and are not 
better explained by another mental disorder (e.g., mood 
disorder, anxiety disorder, dissociative disorder, personality 
disorder, substance intoxication or withdrawal).
Reprinted with permission from the Diagnostic and Statistical Manual 
of Mental Disorders, Fifth Edition (Copyright 2013). American 
Psychiatric Association.
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In most instances, the hyperactivity and impulsivity 
symptoms taper off with age.8 Most adults with ADHD 
struggle mainly with the manifestations of inattention, 
including disorganization, forgetfulness, unreliability, 
and difficulties with planning, task completion, and 
time management.9 In middle-aged9 and older adults,10
the occurrence of depression and anxiety symptoms 
increases as the number of ADHD symptoms increases. 
Studies have found that adolescents and adults with 
ADHD have higher rates of driving-related problems 
(e.g., tickets, accidents) than their peers without 
ADHD.11,12 Other studies have found an association 
between ADHD and some psychopathic traits (e.g., 
blame externalization, rebellious nonconformity,13
antisocial behavior14,15,16). In fact, adult ADHD is 
associated with problems in many spheres of life, 
including work (unemployment), education (low 
attainment), and interpersonal relationships.14
Treatment of ADHD
ADHD is treated with several different kinds 
of stimulant medications, including:
● Methylphenidate (Concerta, Daytrana, Metadate, 
Methylin, Quillivant XR, Ritalin).
● Dexmethylphenidate (Focalin).
● Dextroamphetamine (Dexedrine, ProCentra).
● Dextroamphetamine-amphetamine (Adderall).
● Lisdexamfetamine dimesylate (Vyvanse).
Stimulant medications are available in immediate-
release and sustained-release formulations. The 
immediate-release formulations control ADHD 
symptoms for 3 to 4 hours before wearing off.17 The 
sustained-release pills—also known as controlled- 
and extended-release—control symptoms for 6 to 
10 hours.17 Controlled studies have found that from 
65 percent to 75 percent of children and adolescents 
respond to a single stimulant medication,18 and as 
many as 85 percent may respond when more than one 
stimulant is used.19 Studies have shown variability in 
the adult response rate to stimulant medications,20 but, 
on average, it is about the same as the response rate 
of children and adolescents.17
ADHD is also treated with nonstimulant medications. 
The nonstimulant medications approved by the Food 
and Drug Administration (FDA) include atomoxetine 
(Strattera) and extended-release forms of guanfacine 
(Intuniv) and clonidine (Kapvay). Atomoxetine is 
approved as a treatment for ADHD for people of all 
age groups; extended-release guanfacine and clonidine 
are approved for use by children and adolescents.
Nonstimulant medications may be an alternative for 
people with ADHD for whom prescription stimulants 
are ineffective, cause intolerable side effects, or 
are contraindicated because of another medical 
condition.21,22 Whether nonstimulants are as effective 
as stimulants at controlling ADHD symptoms is an 
open question. Research involving direct comparisons 
of stimulant and nonstimulant medication is lacking. 
Evidence from existing studies and meta-analyses 
suggests that nonstimulants may not be as effective, 
but some experts say longer studies might show 
otherwise, because nonstimulants take several weeks 
to become fully effective.22
Behavioral therapy is also a recognized part of 
ADHD treatment. Adding cognitive–behavioral 
therapy (CBT) to medication can be an effective 
treatment strategy for adults with ADHD.23 CBT 
helps people with ADHD by making them more 
aware of the symptoms and providing some 
coping techniques.23
Substance Use Disorders Among 
Adults With ADHD
Studies have found that adults with ADHD are 
more likely than their peers without ADHD to 
develop an SUD sometime during their lives.24,25,26,27
For example, one large epidemiological study 
(the National Comorbidity Survey Replication 
[NCS-R])28 found that 15.2 percent of adults with 
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ADHD also met criteria for an SUD, compared with 
5.6 percent of adults without ADHD. Substance use 
typically begins earlier,25,27 SUD remission rates 
are slower,29 and the risks of attempted suicide are 
greater in those with co-occurring SUDs and ADHD 
compared with those without ADHD.30 In addition, 
the transition to more severe substance use is more 
likely to occur if someone with an SUD also has 
ADHD.25 Research has also suggested that as the 
severity of ADHD increases, so might the SUD 
risk. In a recent analysis of data from the National 
Epidemiologic Survey on Alcohol and Related 
Conditions, each additional ADHD symptom before 
age 18 was associated with a greater lifetime chance 
of developing substance dependence.31
Although there is no definitive evidence that explains 
the relationship between ADHD and susceptibility 
to developing SUDs, several hypotheses have been 
proposed, including the following:
● Poor executive functioning is intrinsic to ADHD, 
so when adolescents and young adults with ADHD 
are exposed to alcohol, tobacco, and illicit drugs, 
they lack self-restraint and are more likely to use 
substances heavily.32
● ADHD often leads to demoralization and failure, 
factors commonly associated with SUDs in 
adolescents.33
● Studies have shown that the reward system in 
the brain may be impaired in people with ADHD. 
Nicotine and cocaine may activate that system 
in ways that produce effects similar to those 
of stimulant medications used to treat ADHD.34
● Misuse of alcohol and marijuana by people with 
ADHD may be an attempt to alleviate the tense 
feelings that can accompany the disorder.35
● Disorders involving externalizing pathology, such 
as ADHD, antisocial behavior, and SUDs may be 
related to shared genetic risk factors.36
Some research suggests that ADHD increases the 
risk of substance use especially when it co-occurs 
with conduct disorder,34,37 a mental disorder of 
children and adolescents characterized by behavior 
that violates social norms (e.g., bullying, stealing, 
destruction of property).1
College Students, ADHD, and SUDs
Studies have shown that between 2 percent and 
8 percent of college students have ADHD.32
College students with the disorder tend to 
struggle academically and also have difficulty 
making use of study aids, test strategies, and time
management techniques that might help them 
do better.38
Studies of college students with ADHD have 
found associations between the condition and 
increased tobacco and marijuana use.39,40
Research findings on whether ADHD is related 
to alcohol abuse among college students have 
been inconsistent.32
One of the major concerns about prescribing 
stimulant medications for children with ADHD 
is that the stimulants may lead to an increased risk 
of developing an SUD later on. Some research has 
shown just the opposite: that starting stimulant 
therapy earlier lowers this risk, perhaps because 
early stimulant therapy alters brain development.41
However, a meta-analysis published in 2013 that 
included 15 studies found that use of stimulant 
medication by children and adolescents neither 
protected against nor increased risk for SUDs 
later in life.42
ADHD Among Adults With 
Substance Use Disorders
Research on ADHD prevalence among those with 
SUDs has produced widely varying results. The 
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NCS-R28 found that among adults with an SUD, 
10.8 percent met criteria for ADHD, compared 
with an ADHD prevalence of 3.8 percent in adults 
without an SUD. When Australian researchers 
screened people who use cocaine and metham-
phetamine, they found that 45 percent of them had 
ADHD symptoms.43 A study conducted in Spain 
found that about 20 percent of treatment-seeking 
cocaine users had “probable ADHD” based on a 
screening test,44 and a study of patients at alcohol 
and drug detoxification facilities in London found that 
12 percent had undiagnosed ADHD.45 A meta-analysis 
published in 2012 that included 29 studies found that 
23 percent of all SUD subjects had ADHD.35
Misuse of Prescription Stimulant 
Medications
Prescription stimulants can give people a euphoric 
high and are often misused to improve concentration 
and alertness. Large doses can be dangerous, resulting 
in psychosis, seizures, heart attacks, and strokes.46
On college campuses, prescription stimulants 
are sometimes called “smart pills.” Social media 
researchers looking at Twitter messages originating 
from areas where colleges are located have found 
that the number of messages mentioning “Adderall” 
peaks during exam periods.47
Studies have found that college students misuse 
dextroamphetamine-amphetamine more than 
other prescription stimulants.48,49 According to the 
2012 National Survey on Drug Use and Health, 
during the past several years the nonmedical use 
of dextroamphetamine-amphetamine has risen 
sharply among both college-aged adults and adults 
ages 26 and older (see Exhibit 2).
Exhibit 2. Nonmedical Use of Adderall
in the Past Year, by Age Group50
Misuse of prescribed stimulants by 
people with a prescription
Studies of people with ADHD have found that a 
sizable minority (up to about a quarter) misuse 
their medications, usually by taking more than 
the prescribed dose.51,52 A small study of college 
students found that those who reported misusing 
their stimulant medication were more likely to score 
higher on sensation-seeking measures and to report 
recreational use of nicotine, marijuana, hallucinogens, 
opioids, and cocaine than those who reported that 
they had not misused their medication.53 Misuse 
has also been associated with greater hyperactivity 
and impulsivity.54
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Misuse of prescribed stimulants by 
people without a prescription
Much of the research into misuse of prescribed 
stimulants by people without a prescription has 
focused on college students. Studies have found 
that between 4 percent and 20 percent of college 
students have used a prescription stimulant without 
having a legitimate prescription in the past year.55
Many students obtain prescription stimulants from 
friends, who either sell their medications or give 
them away. Roughly a third of college students with 
ADHD report that they have sold or given away their 
medication at least once.56 Research has suggested 
that fraternity and sorority members are at greater risk 
than other students of using prescription stimulants 
without a prescription;57 one study conducted at a 
large public university in the Southeast found that 
55 percent of fraternity members had used 
prescription stimulants without a prescription.58
The main motivation students give for using 
diverted prescription stimulants is to improve school 
performance, with recreational use a distant second. 
In a survey of 4,580 college students, improving 
concentration (65 percent) and help with studying 
(60 percent) were the two most common reasons 
given for misusing prescription stimulants. About half 
as many (31 percent) listed getting high as a reason.49
However, there is currently no evidence that the use 
of prescription stimulants among students without 
ADHD improves their academic performance.59
Research has shown that people who habitually use 
diverted stimulant medication are more likely to 
have ADHD symptoms, so some students misusing 
prescribed stimulants may be self-medicating 
undiagnosed ADHD.60 Researchers have also found 
an association between use of diverted prescription 
stimulants and depression among adolescents and 
young adults.61
The different stimulant medications vary in how 
much they are misused. Surveys have indicated 
that dextroamphetamine-amphetamine is misused 
more often than the methylphenidate medications.49,60
Dextroamphetamine-amphetamine is more 
stimulating62 and stays in the body longer17
than methylphenidate.
People who want a euphoric high from prescription 
stimulants may seek out the immediate-release 
formulations because they can be crushed and 
administered intranasally. The extended-release 
formulations of the stimulant medications are less 
likely than the immediate-release versions to be 
misused because the former are difficult to administer 
intranasally or via injection.33,34
Screening for ADHD in Adults
ADHD can be difficult to distinguish from SUDs 
because some of the presenting symptoms—
restlessness, emotional dysregulation, impulsivity—
are the same.63 It can also be difficult to distinguish 
between ADHD and bipolar disorder.64 When 
ADHD co-occurs with SUDs or mental disorders, 
the complexities only increase. These complexities 
reinforce the importance of collaboration between the 
medical and behavioral health services professionals 
who provide treatment to individuals with these co-
occurring disorders. For example, clients may see 
behavioral health professionals more frequently than 
they see medical providers; consequently, behavioral 
health professionals may become aware first of new 
symptoms, medication side effects, or other problems 
requiring medical attention.
Screening for ADHD in people seeking treatment for 
an SUD can help clinicians make appropriate referrals 
for professional assessment, diagnosis, and evidence-
based ADHD treatments. Below are two examples 
of screening tools.
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Adult ADHD Self-Report Scale-V1.1 (ASRS-V1.1) 
Screener. This six-question screening test65 has been 
endorsed by the World Health Organization and is 
used in epidemiological research. One of the major 
advantages of this screening test is brevity; it takes 
only about a minute, on average, to complete.66
However, the test asks only about the presence
of symptoms; it does not determine whether 
they began in childhood, which is an essential 
component of the official ADHD diagnosis. In a 
large international study of adults seeking treatment 
for SUDs, the test was better at ruling out ADHD 
than reliably identifying the disorder.67
Wender Utah Rating Scale. This 25-question 
screening test68 focuses on recollection of childhood 
symptoms of ADHD. In a study of people seeking 
outpatient treatment for cocaine dependence, it 
was more sensitive (missed fewer cases) than the
ASRS-V1.1 Screener.
Treatment of Co-Occurring ADHD 
and SUDs
Whether stimulant medications should be first-line 
therapy for people with co-occurring ADHD and 
SUDs is an active area of research. Many of the 
studies have focused on people who use cocaine; 
less is known about people with ADHD who use 
other substances.34 Researchers have found that 
methylphenidate is effective at reducing ADHD 
symptoms in people with co-occurring ADHD and 
SUDs.34 However, many studies in this area have 
been small and brief, and the findings have not 
been consistent. For example, in a randomized trial 
of sustained-release methylphenidate in people 
with co-occurring ADHD and cocaine dependence, 
participants who took the medication did not show a 
significantly greater reduction in ADHD symptoms 
than did participants who took a placebo.69
Another question is whether stimulant medications 
might have a positive effect on the SUDs of people 
with co-occurring ADHD and SUDs, particularly 
if some substance use stems from self-medication. 
The evidence from several studies is promising but 
inconclusive.34
The risk of stimulant medication abuse does not seem 
to be appreciably higher in people with co-occurring 
ADHD and SUDs than in those with ADHD alone, 
although the close monitoring and regular visits that 
are part of many studies may make their findings less 
applicable to people receiving care in the community.70
In a study of adults with alcohol use disorder who 
recently stopped drinking, the nonstimulant medication 
atomoxetine was shown to help with ADHD; the 
effects on drinking behavior were inconclusive.71
However, in a study of 70 adolescents with ADHD 
and at least one non-nicotine SUD, the medication 
had no effect on ADHD symptoms or substance use.72
Currently, there are no guidelines for treating people 
with co-occurring ADHD and SUDs, partly because the 
research is limited and findings have been inconsistent.34
Nor are there FDA-approved medications for addictions 
to stimulants. Therefore, treatment of addiction to 
prescription stimulant medication is based on behavioral 
therapy for treating cocaine and methamphetamine 
addictions.73 Depending on the circumstance, the first 
step may be to taper the amount of the drug being used, 
and, after that, cognitive–behavioral or contingency 
management therapy might be effective.73
Prevention of Prescription 
Stimulant Abuse
Prescribing extended-release formulations may 
prevent some stimulant medication abuse. They 
are believed to have less abuse potential than 
the immediate-release formulations because the 
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medication enters the bloodstream more slowly, 
so the stimulating effects also occur more slowly.34
In addition, it is difficult to extract the stimulant 
medication from the extended-release formulations 
for injection or intranasal administration.34 Another 
approach is to avoid the stimulant medications 
altogether and prescribe a nonstimulant such as 
atomoxetine if appropriate.
Strategies proposed for reducing stimulant abuse 
on college campuses include programs to educate 
students about the possible harms of stimulant 
use.58 Researchers have found that students who use 
diverted stimulant medication to cram for tests and 
write papers know little about the medications and 
believe they are harmless. Providing more academic 
support to students so they are less likely to resort to 
taking stimulants has been proposed, as has tighter 
control of prescription stimulants so people with 
ADHD do not have surplus pills to sell or give away.58
Resources
Adult ADHD Self-Report Scale-V1.1 (ASRS-V1.1) 
Screener
www.hcp.med.harvard.edu/ncs/ftpdir/adhd/6Q
_ASRS_English.pdf
Centers for Disease Control and Prevention
www.cdc.gov/ncbddd/adhd
National Institute of Mental Health
www.nimh.nih.gov/health/publications/attention
-deficit-hyperactivity-disorder/index.shtml
National Resource Center on ADHD
www.help4adhd.org
Wender Utah Rating Scale
www.uvm.edu/medicine/ahec/documents/Wender
_Utah_Rating_Scale.pdf
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